|
|
|
|
|
|
|
|
|
06.05.26 - 13:06
|
Cencora, Inc. Reports Climb In Q2 Profit (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Cencora, Inc. (COR) reported earnings for its second quarter that Increases, from the same period last yearThe company's bottom line totaled $1.641 billion, or $8.40 per sha......
|
|
|
|
|
06.05.26 - 12:36
|
Cencora Reports Fiscal 2026 Second Quarter Results (Business Wire)
|
|
|
Revenue of $78.4 billion for the Second Quarter, a 3.8 percent Increase Year-Over-Year
Second Quarter GAAP Diluted EPS of $8.40 and Adjusted Diluted EPS of $4.75
Adjusted Diluted EPS Guidance Range Raised to $17.65 to $17.90 for Fiscal 2026
Cencora Expects to Repurchase $1 Billion in Shares by the End of Calendar 2026CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 second quarter ended March 31, 2026, revenue increased 3.8 percent year-over-year to $78.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $8.40 for the second quarter of fiscal 2026 compared to $3.68 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, increased 7.5 percent to $4.75 in the fiscal second quarter from $4.42 in the prior year second quarter.
Cencora is updating its outlook for fiscal year 2026. The Company does not provide forward-looki...
|
|
|
|
|
|
|
23.04.26 - 16:33
|
RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor (Business Wire)
|
|
|
Pharmaceutical distribution and biopharma services leader joins RIS Rx as the company accelerates GTN Revenue Protection across the pharmaceutical industryIRVINE, Calif.--(BUSINESS WIRE)--#GTN--RIS Rx, the healthcare technology company delivering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, today announced that Tom Doyle has joined the organization as Senior Advisor. Doyle, a widely respected executive with decades of leadership across pharmaceutical distribution, services, and outsourced commercialization, will provide strategic guidance as RIS Rx continues to expand its footprint across the industry.
Tom brings an extraordinary track record to his new role. He spent several years at Cencora Biopharma Services in senior executive leadership, including serving as SVP and Chief Customer Officer. Throughout his tenure, he led teams focused on integrating the full spectrum of Cencora's global capabilities to enhance patient outcomes. Prior to Cencora, he served as ...
|
|
|
01.04.26 - 22:33
|
Cencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings Release (Business Wire)
|
|
|
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 6, 2026.
Participating in the conference call will be:
Robert P. Mauch, President & Chief Executive Officer
James F. Cleary, Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company's website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
To access the call via telephone from within the United States and Canada, dial +1 (833) 461-5787. From outside the United States and Canada, dial +1 (585) 542-9983. The meeting ID for the call will be 280720750 and the access code will be 528015.
A replay of the webcast will be posted on investor.cencora.co...
|
|
|
|
|
|
|
|
|
|
|
23.03.26 - 12:06
|
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners′ Retina Business (Business Wire)
|
|
|
Cencora reaffirms fiscal 2026 financial guidanceCONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora's Retina Consultants of America (“RCA”), a leading management services organization (MSO).
“Driven by a commitment to empower ophthalmologists, EyeSouth Partners has built a strong regional network of physicians that provides high quality patient care,” said Robert P. Mauch, President and Chief Executive Officer of Cencora. “By joining RCA, these physicians will become part of an organization with capabilities designed to provide world-class retina care and be supported by Cencora's longstanding commitment to community physicians,” Mauch continued.
“We look forward to collaborating with the well-trained and respected EyeSouth Partners' physicians as we work ...
|
|
|
|
|
17.03.26 - 16:54
|
XETR: Deletion of Instruments from XETRA - 17.03.2026 (XETRA)
|
|
|
The following instruments on XETRA do have their last trading day on 17.03.2026.
Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 17.03.2026.
ISIN Name
IE00BF0L3536 AIB Group PLC
US03076C1062 Ameriprise Financial Inc.
US0708301041 Bath & Body Works Inc.
US12541W2098 C.H. Robinson Worldwide Inc.
US03073E1055 Cencora Inc.
US1258961002 CMS Energy Corp.
US2371941053 Darden Restaurants Inc.
US28414H1032 Elanco Animal Health Inc.
US29364G1031 Entergy Corp.
US2944291051 Equifax Inc.
US29452E1010 Equitable Holdings Inc.
US31620M1062 Fidelity National Information Services Inc.
US34959J1088 Fortive Corp.
US35137L1052 Fox Corp.
US3647601083 Gap Inc.
US4165151048 Hartford Insurance Group Inc.
US8326964058 J.M. Smucker Co.
IE0004927939 Kingspan Group PLC
US5178341070 Las Vegas Sands Corp.
US5261071071 Lennox International Inc.
US5717481023 Marsh & McLennan Cos. Inc.
US6558441084 Norfolk Southern Corp.
US7445731067 Public Service Enterprise Group Inc.
US7591EP1005 Regio...
|
|
|
17.03.26 - 14:18
|
Cencora CFO James Cleary Set To Retire (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Cencora, Inc. (COR), a distributor of pharma products, Tuesday announced that its Chief financial Officer and Executive Vice President, James Cleary will retire on June 30.T......
|
|
|
|
|
17.03.26 - 13:33
|
Cencora Announces Financial Leadership Transition (Business Wire)
|
|
|
Cencora reaffirms fiscal 2026 financial guidanceCONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Mr. Cleary will assist in the search process and will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition.
Mr. Cleary, 62, has served as Cencora's CFO since November 2018. He joined the Company in February 2015, following its acquisition of MWI Veterinary Supply, where he had served as Chief Executive Officer for over a decade.
“On behalf of the Board and Enterprise Leadership Team, I want to thank Jim for his years of pragmatic leadership, strategic insight and consistent financial stewardship,” said Robert P. Mauch, President and Chief Executive Officer of Cencora. “Jim retires with an outstanding...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
